ADPT - Adaptive Biotechnologies Corp
14.04
-0.170 -1.211%
Share volume: 1,229,374
Last Updated: 04-28-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.20%
PREVIOUS CLOSE
CHG
CHG%
$14.21
-0.17
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-07-2024 | 08-01-2024 | 11-07-2024 | 03-03-2025 | 05-01-2025 | 08-05-2025 | 11-05-2025 | 02-26-2026 | |
| Assets | |||||||||
| Total Assets | 620.323 M | 584.872 M | 558.506 M | 539.376 M | 510.852 M | 496.637 M | 490.610 M | 512.736 M | |
| Current Assets | 374.034 M | 351.552 M | 308.345 M | 283.752 M | 256.489 M | 261.856 M | 281.435 M | 300.185 M | |
| Inventories | 13.291 M | 13.214 M | 11.955 M | 8.440 M | 8.684 M | 8.403 M | 9.933 M | 9.820 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 237.639 M | 232.056 M | 205.245 M | 174.374 M | 142.778 M | 154.710 M | 157.735 M | 156.485 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 71.233 M | 59.824 M | 38.084 M | 47.920 M | 50.646 M | 43.163 M | 55.034 M | 70.495 M | |
| Total Non-current Assets | 0.000 | 0.000 | 23.866 M | 33.660 M | 39.355 M | 24.100 M | 4.037 M | 13.234 M | |
| Property Plant Equipment | 65.260 M | 55.418 M | 51.314 M | 48.616 M | 44.430 M | 41.055 M | 37.498 M | 34.107 M | |
| Other Assets | 177.639 M | 177.902 M | 198.847 M | 207.008 M | 209.933 M | 193.726 M | 171.677 M | 178.444 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 620.323 M | 584.872 M | 558.506 M | 539.376 M | 510.852 M | 496.637 M | 490.610 M | 512.736 M | |
| Total liabilities | 345.557 M | 343.442 M | 334.932 M | 336.891 M | 320.631 M | 317.101 M | 286.357 M | 287.735 M | |
| Total current liabilities | 82.952 M | 88.126 M | 87.627 M | 98.053 M | 87.809 M | 92.141 M | 83.361 M | 89.915 M | |
| Accounts Payable | 12.170 M | 9.867 M | 7.351 M | 7.265 M | 6.362 M | 6.908 M | 10.267 M | 6.467 M | |
| Other liabilities | 86.900 M | 84.390 M | 81.824 M | 79.168 M | 76.458 M | 74.433 M | 72.381 M | 70.248 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 131.545 M | 132.082 M | 132.700 M | 132.414 M | 131.550 M | 130.495 M | 129.409 M | 126.566 M | |
| Other liabilities | 86.900 M | 84.390 M | 81.824 M | 79.168 M | 76.458 M | 74.433 M | 72.381 M | 70.248 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 274.913 M | 241.603 M | 223.773 M | 202.709 M | 190.423 M | 179.717 M | 204.435 M | 218.793 M | |
| Common stock | 1.467 B | 1.480 B | 1.493 B | 1.506 B | 1.524 B | 1.539 B | 1.554 B | 1.582 B | |
| Retained earnings | -1.192 B | -1.238 B | -1.270 B | -1.304 B | -1.334 B | -1.359 B | -1.350 B | -1.363 B |